Tango Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Tango Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 47% to $36,527,000. The net income raised on -$101,744,000 and profit margin reached -279%. Total operating expenses were $150,700,000.
Profit Margin
| 2019 | 24.64M | -14.09M | -57.18% |
|---|---|---|---|
| 2020 | 7.65M | -51.86M | -677.43% |
| 2021 | 37.04M | -58.23M | -157.21% |
| 2022 | 24.86M | -108.17M | -435.14% |
| 2023 | 36.52M | -101.74M | -278.54% |
TNGX Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 36.52M | 24.86M | 37.04M | 7.65M | 24.64M |
Cost of revenue | 115.19M | 4.02M | 1.96M | 1.62M | 31.45M |
Gross profit | -78.67M | 20.83M | 35.07M | 6.03M | -6.80M |
Operating exp. | |||||
Research and development | 115.19M | 105.90M | 77.63M | 49.99M | 32.27M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 150.7M | 135.93M | 95.23M | 59.85M | 7.97M |
Operating income | -114.17M | -111.07M | -58.19M | -52.2M | -15.16M |
Other income (expenses), net | 12.56M | 2.94M | 247K | 228K | 1.06M |
Income before tax | -101.61M | -108.12M | -57.94M | -51.97M | -14.09M |
Income tax expense | 134K | 54K | 292K | -108K | 0 |
Net income | -101.74M | -108.17M | -58.23M | -51.86M | -14.09M |
Earnings per share | |||||
Basic EPS | -1.08 | -1.23 | -0.94 | -1.62 | -1.57 |
Diluted EPS | -1.08 | -1.23 | -0.94 | -1.62 | -1.57 |
| Data source | Data source | Data source | Data source |